Log in to save to my catalogue

A Novel Multiplex Based Platform for Osteoarthritis Drug Candidate Evaluation

A Novel Multiplex Based Platform for Osteoarthritis Drug Candidate Evaluation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_411709

A Novel Multiplex Based Platform for Osteoarthritis Drug Candidate Evaluation

About this item

Full title

A Novel Multiplex Based Platform for Osteoarthritis Drug Candidate Evaluation

Publisher

Cham: Springer International Publishing

Journal title

Annals of biomedical engineering, 2020-10, Vol.48 (10), p.2438-2448

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Osteoarthritis (OA) is characterized by irreversible cartilage degradation with very limited therapeutic interventions. Drug candidates targeted at prototypic players had limited success until now and systems based approaches might be necessary. Consequently, drug evaluation platforms should consider the biological complexity looking beyond well-kn...

Alternative Titles

Full title

A Novel Multiplex Based Platform for Osteoarthritis Drug Candidate Evaluation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_411709

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_411709

Other Identifiers

ISSN

0090-6964,1573-9686

E-ISSN

1573-9686

DOI

10.1007/s10439-020-02539-4

How to access this item